Cargando…
Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
Background: Amyotrophic lateral sclerosis (ALS) is a multisystemic, progressive, neurodegenerative disorder. Despite it being generally fatal within a period of 2–4 years, it is highly heterogeneous; as a result, survival periods may vary greatly among individual patients. Biomarkers can serve as to...
Autores principales: | González-Mingot, Cristina, Miana-Mena, Francisco Javier, Iñarrea, Pedro José, Iñiguez, Cristina, Capablo, José Luis, Osta, Rosario, Gil-Sánchez, Anna, Brieva, Luis, Larrodé, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219422/ https://www.ncbi.nlm.nih.gov/pubmed/37240666 http://dx.doi.org/10.3390/jcm12103560 |
Ejemplares similares
-
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
por: Ternette, Nicola, et al.
Publicado: (2013) -
Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker
por: Moreno-García, Leticia, et al.
Publicado: (2021) -
Mitochondrial aconitase suppresses immunity by modulating oxaloacetate and the mitochondrial unfolded protein response
por: Kim, Eunah, et al.
Publicado: (2023) -
Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues
por: Singh, Keshav K, et al.
Publicado: (2006) -
Preventive treatment can reverse cognitive impairment in chronic migraine
por: González-Mingot, Cristina, et al.
Publicado: (2022)